Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2025)

Guided Therapeutics has disclosed Interest Coverage Ratio across 16 years of filings, most recently posting 3.86 for Q4 2025.

• Interest Coverage Ratio for Q4 2025 came in at 3.86, up 3.17% year-over-year; the trailing twelve-month figure through Dec 2025 was 3.84 (up 30.55% YoY), and the FY2025 annual result was 3.84, up 30.52% from the prior year.
• Interest Coverage Ratio came in at 3.86 for Q4 2025 at Guided Therapeutics, down from 3.76 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 0.82 in Q3 2021 to a low of 21.81 in Q2 2023.
• The 5-year median for Interest Coverage Ratio is 5.03 (2025), against an average of 6.52.
• Across the five-year window, Interest Coverage Ratio slumped 863.18% in 2022 and surged 59.96% in 2024, its largest moves.
• Guided Therapeutics' Interest Coverage Ratio stood at 4.35 in 2021, then slumped by 211.33% to 13.54 in 2022, then jumped by 50.26% to 6.74 in 2023, then soared by 40.84% to 3.99 in 2024, then advanced by 3.17% to 3.86 in 2025.
• The last three Interest Coverage Ratio figures came in at 3.86 (Q4 2025), 3.76 (Q3 2025), and 4.86 (Q2 2025), per Business Quant data.